Automated pressure injury assessment tool
A study in Nursing Research reports that automated pressure injury risk assessment system, which is built into an electronic health record and doesn’t require…
Web Exclusives
FDA approves ECG accessory for Apple Watch
The U.S. Food and Drug Administration (FDA) has approved a medical device accessory for the Apple Watch that can detect arrhythmia and display on…
Alarming childhood obesity trend
If current trends in child obesity continue, more than 57% of today’s children in the U.S. will have obesity at age 35, according to…
New test may help determine best drug for cystic fibrosis patients
A new test may make it easier to determine the best drug for patients with cystic fibrosis, replacing the current trial and error method,…
FDA approves first two-drug regimen for HIV
On Nov. 21, the U.S. Food and Drug Administration (FDA) approved Juluca, the first treatment regimen containing two drugs to treat certain adults with…
Walking problems and cardiovascular disease risk
The more risk factors for cardiovascular disease people aged 60-78 have, the faster walking speed declines, according to a study in the Journal of…
Mentorship programs and novice nursing faculty
Caring, supportive mentors can help ease faculty shortage. Takeaways: Mentoring is one strategy to help solve nursing faculty shortages. Good mentors lie at the…
FDA approves digital tracking pill
On Nov. 13, the U.S. Food and Drug Administration (FDA) approved Abilify MyCite, a pill with a sensor that digitally tracks if patients have…
FDA permits marketing of device to help reduce opioid withdrawal symptoms
On Nov. 15, the U.S. Food and Drug Administration (FDA) granted a new indication to an electric stimulation device (NSS-2 Bridge) for use in…
Behavioral emergency response team improves safety
A behavioral emergency response team helps de-escalate behavioral emergencies, thereby reducing assaults and use of restraints, according to a study in Worldviews on Evidence-based…
FDA approves first treatment for Erdheim-Chester Disease
On Nov. 6, the U.S. Food and Drug Administration (FDA) expanded approval of Zelboraf (vemurafenib) to treat certain adult patients with Erdheim-Chester Disease. (more…)
HIV patients at greater risk for heart, kidney disease
Patients with HIV who are at high risk for a heart attack or stroke are also at substantially greater risk for chronic kidney disease…
Automated pressure injury assessment tool
A study in Nursing Research reports that automated pressure injury risk assessment system, which is built into an electronic health record and…
FDA approves ECG accessory for Apple Watch
The U.S. Food and Drug Administration (FDA) has approved a medical device accessory for the Apple Watch that can detect arrhythmia and…
Alarming childhood obesity trend
If current trends in child obesity continue, more than 57% of today’s children in the U.S. will have obesity at age 35,…
New test may help determine best drug for cystic fibrosis patients
A new test may make it easier to determine the best drug for patients with cystic fibrosis, replacing the current trial and…
FDA approves first two-drug regimen for HIV
On Nov. 21, the U.S. Food and Drug Administration (FDA) approved Juluca, the first treatment regimen containing two drugs to treat certain…
Walking problems and cardiovascular disease risk
The more risk factors for cardiovascular disease people aged 60-78 have, the faster walking speed declines, according to a study in the…
Mentorship programs and novice nursing faculty
Caring, supportive mentors can help ease faculty shortage. Takeaways: Mentoring is one strategy to help solve nursing faculty shortages. Good mentors lie…
FDA approves digital tracking pill
On Nov. 13, the U.S. Food and Drug Administration (FDA) approved Abilify MyCite, a pill with a sensor that digitally tracks if…
FDA permits marketing of device to help reduce opioid withdrawal symptoms
On Nov. 15, the U.S. Food and Drug Administration (FDA) granted a new indication to an electric stimulation device (NSS-2 Bridge) for…
Behavioral emergency response team improves safety
A behavioral emergency response team helps de-escalate behavioral emergencies, thereby reducing assaults and use of restraints, according to a study in Worldviews…
FDA approves first treatment for Erdheim-Chester Disease
On Nov. 6, the U.S. Food and Drug Administration (FDA) expanded approval of Zelboraf (vemurafenib) to treat certain adult patients with Erdheim-Chester…
HIV patients at greater risk for heart, kidney disease
Patients with HIV who are at high risk for a heart attack or stroke are also at substantially greater risk for chronic…
Test Your Knowledge
Cannabis TYK
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.NurseLine Newsletter
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.